Groundbreaking Elephant Herpesvirus Vaccine Shows Promise in Protecting Endangered Species

Researchers have developed a promising new vaccine against elephant endotheliotropic herpesvirus (EEHV), a deadly disease causing high mortality in young elephants, with initial trials showing it safely stimulates immune response in adult elephants. The next step is testing in younger, more vulnerable elephants, aiming to prevent future deaths and aid conservation efforts.